Halozyme Therapeutics
HALO
#2319
Rank
$6.55 B
Marketcap
$51.77
Share price
-1.60%
Change (1 day)
48.89%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $1.68 Billion USD

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are $1.68 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$1.64 B-1.33%
2022-12-31$1.67 B84.22%
2021-12-31$0.90 B111.59%
2020-12-31$0.42 B-9.54%
2019-12-31$0.47 B147.76%
2018-12-31$0.19 B-38.58%
2017-12-31$0.31 B5.98%
2016-12-31$0.29 B111.83%
2015-12-31$0.13 B11.37%
2014-12-31$0.12 B2.33%
2013-12-31$0.12 B41.81%
2012-12-31$85.87 M56.54%
2011-12-31$54.85 M-22.73%
2010-12-31$70.99 M1.06%
2009-12-31$70.24 M14.81%
2008-12-31$61.18 M33.9%
2007-12-31$45.69 M98.58%
2006-12-31$23.01 M898.98%
2005-12-31$2.3 M45.84%
2004-12-31$1.57 M477.61%
2003-12-31$0.27 M-55.18%
2002-12-31$0.61 M18450.93%
2001-12-31$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.66 B-60.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$58.23 B 3,366.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.60 B 1,007.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$128.21 B 7,531.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.84 B 3,521.58%๐Ÿ‡ซ๐Ÿ‡ท France
$109.55 B 6,420.72%๐Ÿ‡บ๐Ÿ‡ธ USA